Tianjin Chase Sun Pharmaceutical Co Ltd (300026):企業の財務・戦略的SWOT分析

◆英語タイトル:Tianjin Chase Sun Pharmaceutical Co Ltd (300026) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH309176FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tianjin Chase Sun Pharmaceutical Co Ltd (Chase Sun) is a medicine and health industry group. The company research, develops, produces, and markets various pharmaceutical products. It offers products such as Chinese herb preparations, Chinese medicinal granules, synthetic drugs, biotech drugs, medical apparatus and internet based therapy, among others. Chase Sun also produces synthetic drugs and preparation products such as polysaccharides, peptides, anti-cancer drugs, and other drugs. The company also provides research and development services. It conducts research programs for the treatment of sepsis, pulmonary hypertension, cardiovascular disease, ischemic stroke, HCV, vascular disease, psychosis, chemotherapy, and others. Chase Sun is headquartered in Tianjin, China.

Tianjin Chase Sun Pharmaceutical Co Ltd Key Recent Developments

Feb 25,2021: Hongri Pharmaceutical won the title of National Advanced Group for Poverty Alleviation
Jan 21,2021: Hongri Pharmaceutical won the AAA credit rating of 2020 pharmaceutical industry enterprises
Aug 17,2020: Starpharma signs new DEP partnership with Chase Sun

This comprehensive SWOT profile of Tianjin Chase Sun Pharmaceutical Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Tianjin Chase Sun Pharmaceutical Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Tianjin Chase Sun Pharmaceutical Co Ltd – Key Information
Tianjin Chase Sun Pharmaceutical Co Ltd – Overview
Tianjin Chase Sun Pharmaceutical Co Ltd – Key Employees
Tianjin Chase Sun Pharmaceutical Co Ltd – Key Employee Biographies
Tianjin Chase Sun Pharmaceutical Co Ltd – Key Operational Heads
Tianjin Chase Sun Pharmaceutical Co Ltd – Major Products and Services
Tianjin Chase Sun Pharmaceutical Co Ltd – History
Tianjin Chase Sun Pharmaceutical Co Ltd – Company Statement
Tianjin Chase Sun Pharmaceutical Co Ltd – Locations And Subsidiaries
Tianjin Chase Sun Pharmaceutical Co Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Tianjin Chase Sun Pharmaceutical Co Ltd – Business Description
Tianjin Chase Sun Pharmaceutical Co Ltd – Corporate Strategy
Tianjin Chase Sun Pharmaceutical Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Tianjin Chase Sun Pharmaceutical Co Ltd – Strengths
Tianjin Chase Sun Pharmaceutical Co Ltd – Weaknesses
Tianjin Chase Sun Pharmaceutical Co Ltd – Opportunities
Tianjin Chase Sun Pharmaceutical Co Ltd – Threats
Tianjin Chase Sun Pharmaceutical Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Tianjin Chase Sun Pharmaceutical Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Tianjin Chase Sun Pharmaceutical Co Ltd, Key Information
Tianjin Chase Sun Pharmaceutical Co Ltd, Key Ratios
Tianjin Chase Sun Pharmaceutical Co Ltd, Share Data
Tianjin Chase Sun Pharmaceutical Co Ltd, Major Products and Services
Tianjin Chase Sun Pharmaceutical Co Ltd, History
Tianjin Chase Sun Pharmaceutical Co Ltd, Key Employees
Tianjin Chase Sun Pharmaceutical Co Ltd, Key Employee Biographies
Tianjin Chase Sun Pharmaceutical Co Ltd, Key Operational Heads
Tianjin Chase Sun Pharmaceutical Co Ltd, Other Locations
Tianjin Chase Sun Pharmaceutical Co Ltd, Subsidiaries
Tianjin Chase Sun Pharmaceutical Co Ltd, Key Competitors
Tianjin Chase Sun Pharmaceutical Co Ltd, SWOT Analysis
Tianjin Chase Sun Pharmaceutical Co Ltd, Ratios based on current share price
Tianjin Chase Sun Pharmaceutical Co Ltd, Annual Ratios
Tianjin Chase Sun Pharmaceutical Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Tianjin Chase Sun Pharmaceutical Co Ltd (300026):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Syneos Health Inc:企業の戦略・SWOT・財務分析
    Syneos Health Inc - Strategy, SWOT and Corporate Finance Report Summary Syneos Health Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Hess Corporation (HES)-エネルギー分野:企業M&A・提携分析
    Summary Hess Corporation (Hess) is a global independent energy company which carries out the exploration and production of crude oil and natural gas. It primarily operates in US, Denmark, Equatorial Guinea, the Joint Development Area of Malaysia/Thailand (JDA), Malaysia, and Norway. It offers fee-ba …
  • CIMIC Group Limited:企業のM&A・事業提携・投資動向
    CIMIC Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CIMIC Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Chugai Pharmaceutical Co., Ltd.:企業の戦略・SWOT・財務情報
    Chugai Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chugai Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Agfa-Gevaert N.V.:企業の戦略・SWOT・財務情報
    Agfa-Gevaert N.V. - Strategy, SWOT and Corporate Finance Report Summary Agfa-Gevaert N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Enea AB (ENEA):企業の財務・戦略的SWOT分析
    Summary Enea AB (Enea) is a technology company that provides software products, services and solutions. The company’s product portfolio consists of NFV virtualization platforms, operating systems, device and network management, traffic intelligence, 5g data management, access management and policy c …
  • Pioneer Corporation:企業の戦略・SWOT・財務分析
    Pioneer Corporation - Strategy, SWOT and Corporate Finance Report Summary Pioneer Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Coresa Sa:企業の戦略・SWOT・財務分析
    Coresa Sa - Strategy, SWOT and Corporate Finance Report Summary Coresa Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Ivenix Inc-医療機器分野:企業M&A・提携分析
    Summary Ivenix Inc (Ivenix), formerly Fluidnet Corp is a medical technology company that offers infusion therapy solutions. The company offers products such as intravenous drug infusion pump systems and IV smart pump. Its IV smart pump eliminates air from fluid bag and IV lines to reduce number of a …
  • Ward Petroleum Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Ward Petroleum Corp (Ward Petroleum) is an independent oil and gas exploration and production company. The company acquires, explores, develops and produces natural gas and petroleum resources. It drills horizontal wells in Garfield County, Oklahoma and Anadarko Basin in Mid-Continent region …
  • Hokuriku Electric Power Co (9505):企業の財務・戦略的SWOT分析
    Hokuriku Electric Power Co (9505) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Protea Biosciences Group Inc (PRGB)-医療機器分野:企業M&A・提携分析
    Summary Protea Biosciences Group Inc (Protea) is a biotechnology company that develops mass spectometry solutions. The company offers technology for the characterization, identification, and quantitation of biologically-important molecules for research, pharmaceutical development, and diagnostic app …
  • Roland DG Corp (6789):企業の財務・戦略的SWOT分析
    Roland DG Corp (6789) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Cepheid:医療機器:M&Aディール及び事業提携情報
    Summary Cepheid, a subsidiary of Danaher Corporation, is a molecular diagnostic company that develops, manufactures and markets molecular systems and tests for clinical and non-clinical markets. The company offers in vitro diagnostic tests for health care associated infections, critical infectious d …
  • Blackbird Energy Inc (BBI):石油・ガス:M&Aディール及び事業提携情報
    Summary Blackbird Energy Inc (Blackbird Energy), formerly Blackbird Investments Inc, is an independent oil and gas exploration and development company that acquires, explores, produces and develops oil and gas properties in Western Canada. The company holds interests in Elmworth Project which concen …
  • Itochu Chemical Frontier Corp-製薬・医療分野:企業M&A・提携分析
    Summary Itochu Chemical Frontier Corp (ICF), formerly Ando Kaseihin KK, a subsidiary of Itochu Corporation, is a chemical company that manufactures and markets chemical products. The company operates in intermediate chemical division, silicone and adhesive division, osaka and nagoya division, perfor …
  • Faes Farma SA (FAE):製薬・医療:M&Aディール及び事業提携情報
    Summary Faes Farma SA (Faes Farma) develops, manufactures and commercializes pharmaceutical products and raw materials. The company offers prescription drugs, generic drugs, food supplements, over-the-counter (OTC) medications, baby foods, skin-care treatment products. It exports raw-materials and f …
  • Iberdrola, S.A.:企業のM&A・事業提携・投資動向
    Iberdrola, S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Iberdrola, S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Godrej Consumer Products Limited:企業のM&A・事業提携・投資動向
    Godrej Consumer Products Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Godrej Consumer Products Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Royal BAM Group nv:企業の戦略・SWOT・財務分析
    Royal BAM Group nv - Strategy, SWOT and Corporate Finance Report Summary Royal BAM Group nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆